Another study constructed an integrated model using CT radiomics, CT radiological features and clinical features to predict EGFR mutations in adenocarcinoma patients, achieving AUCs of 0.849 and 0.835 in the training and validation groups, respectively (41). The gene discussed is EGFR; the disease is adenocarcinoma.